Table 1 Characteristics of clinical samples
| Â | Â | miRNA microarray | Validation analysis | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
DM a | Wild-type | DM | HC b | IVDH c | |||||||
| Â | Â | Â | Total | A/A | A/G | G/G | Total | A/A | A/G | ||
Number | Total | 4 | 4 | 18 | 46 | 21 | 21 | 4 | 5 | 4 | 1 |
Stage 1 | 0 | – | 4 | – | – | – | – | – | – | – | |
Stage 2 | 0 | – | 5 | – | – | – | – | – | – | – | |
Stage 3 | 1 | – | 4 | – | – | – | – | – | – | – | |
Stage 4 | 3 | – | 5 | – | – | – | – | – | – | – | |
Gender | Male | 1 | 3 | 10 | 11 | 4 | 4 | 3 | 5 | 4 | 1 |
Female | 3 | 1 | 8 | 35 | 17 | 17 | 1 | 0 | 0 | 0 | |
Age in months | Median | 159 | 151 | 159 | 140 | 133 | 155 | 152 | 162 | 142 | 163 |
Range | 142–161 | 100–173 | 110–187 | 89–194 | 94–178 | 89–194 | 100–173 | 116–173 | 116–173 | – | |